What does the total bilirubin to aspartate aminotransferase (AST) ratio indicate?

Total Bilirubin to AST Ratio

The total bilirubin to AST ratio is not a validated or recognized clinical tool in standard hepatology practice, and you should instead focus on the AST to ALT ratio and the pattern of bilirubin elevation relative to aminotransferases to guide your diagnostic approach.

What You Should Actually Be Using

AST:ALT Ratio for Fibrosis Assessment

An AST:ALT ratio >1 indicates advanced fibrosis or cirrhosis in adults with liver disease 1. This ratio maintains its utility even when both values fall within normal reference ranges, making it valuable for risk stratification 1. This is the validated ratio that should guide your clinical decision-making regarding fibrosis risk.

Bilirubin-to-Aminotransferase Pattern for Disease Classification

The relationship between bilirubin and aminotransferases helps distinguish between:

• Hepatocellular injury: Aminotransferases (ALT/AST) elevated disproportionately to bilirubin
• Cholestatic injury: Bilirubin and alkaline phosphatase elevated in excess of aminotransferases 2

Clinical Decision Algorithm

When evaluating abnormal liver tests:

1. First, determine the pattern of injury:

   • If ALT/AST >> bilirubin → hepatocellular pattern
   • If bilirubin/ALP >> ALT/AST → cholestatic pattern

2. Then, assess fibrosis risk using AST:ALT ratio:

   • AST:ALT >1 → suspect advanced fibrosis/cirrhosis, expedite evaluation 1
   • AST:ALT <1 → less likely advanced disease

3. Evaluate severity and urgency:

   • Elevated bilirubin WITH elevated aminotransferases signals higher risk and warrants expeditious evaluation 2
   • Very high aminotransferases (>1000 U/L) with even minimal bilirubin elevation (1.1-2.5 mg/dL) carries significantly increased risk for poor outcomes 3

Critical Pitfalls

Do not rely on a bilirubin-to-AST ratio as this is not a validated clinical metric. The evidence consistently emphasizes:

• The AST:ALT ratio (not bilirubin:AST) for fibrosis assessment 1
• The absolute pattern of elevation (which tests are elevated relative to others) rather than ratios between bilirubin and individual aminotransferases 2

Both AST and ALT can be normal even in cirrhosis, so normal aminotransferases do not exclude advanced liver disease 1. Conversely, very high aminotransferases (>500 U/L) with normal bilirubin (≤1.0 mg/dL) rarely progress to severe outcomes, but even minimal bilirubin elevation (1.1-2.5 mg/dL) dramatically increases risk 3.

Prognostic Considerations

When both AST and bilirubin are elevated together, this combination predicts worse outcomes:

• In COVID-19 patients, elevated AST and total bilirubin independently predicted mortality 4
• Post-hepatectomy, bilirubin and INR on day 3 were the strongest predictors of liver failure 5
• AST >2× upper reference limit with elevated bilirubin indicates >5% 10-year risk of major adverse liver outcomes 6